🔊 Calling all clinicians: Expand your knowledge of #genetherapy + #celltherapy while earning CME for free! Join us for this on-demand CME series designed to help clinicians stay up to date with advances in #CGT treatment options and their potential to change the course of disease for genetic conditions and cancers. Cell and Gene Therapy: What Clinicians Need to Know to Counsel and Orient Their Patients is available through April 30, 2025. This opportunity is provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health in collaboration with ASGCT and National Organization for Rare Disorders. https://bit.ly/3T14Kqj
American Society of Gene & Cell Therapy’s Post
More Relevant Posts
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
-
Strategic and Visionary Leader; Proven record of successful client relationship management; Deep oncology experience
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Associate Talent Sourcer @Fortrea | working with talents across Nordics, Romania, and DACH
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Tune in to our recent webinar titled 'Navigating the pathway to first in human – A case study of a novel cell therapy' if you are looking for support to progress your #ATMP from the pre-clinical stage through to first in human clinical trials. In this webinar, the Cell and Gene Therapy Catapult’s Non-clinical and Health Economics and Market Access teams illustrate how a non-clinical programme is designed, and how to incorporate health economics into the clinical development plan at an early-stage to optimise the adoption potential of an #AdvancedTherapy. Watch now: https://buff.ly/3trwL0k #CellTherapy #GeneTherapy #AdvancedTherapies #ClinicalTrials
Navigating the pathway to first in human – A case study of a novel cell therapy
ct.catapult.org.uk
-
Rapid Whole Genome Sequencing (rWGS) is a first-tier test for critically ill infants in the NICU/PICU. An international study involving 21 patients demonstrated that rWGS led to - Definite diagnosis in 57.5% of patients - Unsuspected diagnosis in 7 patients - Care adjustments including gene therapy, off-label drug trial, and two condition-specific treatments Our rWGS delivers written results in as few as 5 days and includes analysis of tandem repeat disorders and RNAseq, aiding in diagnosis of complex conditions. Learn more: https://bit.ly/3Jt6FPZ #ThinkBG #RapidGenomeSequencing
-
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
-
Clinical trials in #ophthalmology require special considerations at each stage, including trial design, recruitment strategies, patient outreach and much more. Success means putting patients and their caregivers first. Our panel of speakers will address advances in trial design specific to rare/genetic diseases of the eye, focusing on cell and gene therapy and the need to work collaboratively in this space. Register today. #opthalmologyclinicaltrials #rarediseases #clinicaltrials #cellandgenetherapy
Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
share.postbeyond.com
Senior Manager, Professional Development, American Society of Addiction Medicine
2moGreat work by Muhimbili University of Health and Allied sciences and the ASGCT Global Outreach Committee in developing the curriculum for this course.